Audit of RBC Transfusion in Premature Infants 2001 Dr Ho Hing Tung (Paediatrics) Dr Sherman Lee (Clinical Audit) Dr Raymond Chu (Haematology) Pamela Youde.

Slides:



Advertisements
Similar presentations
Late Exogenous Surfactant Therapy In Preterm Neonates With Respiratory Distress Syndrome By Dr. Mohamed El- Sherbini.
Advertisements

Fluid and Electrolyte Homeostasis in the Neonate
Blood Transfusion in The Neonate Dr.Boskabadi Neonatologist.
Chapter3 Problems of the neonate and young infant - Neonatal resuscitation.
Tutorial: Pulmonary Function--Dr. Bhutani Clinical Case 695 g male neonate with RDS, treated with surfactant and on ventilatory 18 hours age:
1 Using the new UK-WHO growth charts with new born babies and preterm infants Presentation F Adapted from training materials of the Royal College of Paediatrics.
Perinatal Safety Initiative: Eliminating Elective Delivery
Retinopathy of Prematurity Neonatal Audit 2010 Dr Anjan Bhaduri Mr Syed Ali Dr Gopal Krishana Singh.
Chapter 15 Newborn (Perinatal) Guidelines ( )
Copyright restrictions may apply A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency.
Archives of Iranian Medicine, Volume 13, Number 5, September 2010.
Early Newborn Discharge and Readmission for Mild and Severe Jaundice Jacqueline Grupp-Phelan, James A. Taylor, Lenna L. Liu and Robert L. Davis University.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
Early Nutritional Support Influences Body Composition at Four Months Corrected Age in Very Low Birth Weight Preterm Infants Ellen C Christiansen, MD 1,
Nutrition and Food Services Department Child growth charts e-learning tool Judith Myers and Kay Gibbons October 2011.
Annual Cost of NEC Reference: Pediatrics 2002;109, ;Impact of Necrotizing Enterocolitis on Length of Stay and Hospital Charges in Very Low Birth.
CPAP Murila fv. Respiratory distress syndrome 28% of neonatal deaths are due to prematurity The most common respiratory disorder in the preterm is Respiratory.
An interdisciplinary approach to care of infants with bronchopulmonary dysplasia. Alfred L. Gest, MD.
Treating preterm infants with Surfactant: an overview of application techniques and results Angela Kribs, Children‘s Hospital, University of Cologne.
Evidence Based Medication Use in the NICU: Erythropoietin Dan Ellsbury MD Director, Continuous Quality Improvement Pediatrix Medical Group.
Retinopathy of Prematurity: A Neglected Public Health Issue Krishnendu Sarkar Professor Regional Institute of Ophthalmology Kolkata.
Author: Nagy Iulia Andrea Coordinator: Simon Márta, PhD, Lecturer Coauthor: Ortopan Maria, Oana Andrea Edina.
NICU Individual Compliance Metrics Monica Larsen RN GBMC NICU.
Blood Transfusion in The Neonate Presented by R1 簡維宏.
Hannah Spiers Samuel Agaba Bwindi Community Hospital Neonatal Audit.
CMV +ve Control Introduction cCMV affects ~1% of all newborns born annually in the U.S. ~ 10% born with symptoms typically associated with cCMV Most develop.
Dr. M.Thomas. CUHT.. Sick Neonates are one of the most heavily transfused group of patients in modern medicine. Survival has increased. ELBW - 50% receive.
The Health Roundtable Introduction of a day admission model for implementation of non-invasive ventilation Presenter: Linda Rautela Austin Innovation Poster.
The SToP-BPD study Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants Clinical lesson Oct 2011.
Afebrile Infants With UTI and the Risk for Bacteraemia Journal Club Sheffield Children’s Hospital Naheed Maher 7 th January 2015.
An Evidence-Based Approach to Transfusion of the Preterm Infant
The Impact of Birth Spacing on Subsequent Feto-Infant Outcomes among Community Enrollees of a Federal Healthy Start Project Hamisu M. Salihu, MD, PhD Euna.
Definitions Infant: 0 to 1 year babies. Neonates: 0-28 days babies (4 weeks). Early Neonates : 0-7 days babies(1 week). Under 5 children or child: 0-5.
Guideline for Metropolitan Paediatric Wards & Emergency Departments 1st edition Humidified High Flow Nasal Cannula Oxygen.
Platelet Transfusions Indications, dose and administration
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics ANAEMIA a Hb below reference range for age, sex and gestation Ferritin
Prevention of Central Line-Related Bloodstream Infections (CRBSI) on NNU Wales Neonatal Audit and Outcomes Day Cardiff, 07/10/2015 Sandar S, Ratcliffe.
Antibiotics on the postnatal ward A n audit and cost-analysis of current practices Dr Rachel Hayward & Dr Sybil Barr UHW Neonatal Unit.
Dr. PremKumar Pitchaikani Dr. Ramona Dumitru Pneumothorax in Wales 2014 
Introduction Extremely low birth weight (ELBW) infants are those with birth weight of
호흡기내과 R1. 이정미. INTRODUCTION Acute respiratory failure (ARF) is the most common reason for admission in the intensive care unit (ICU), often requiring.
1 Sex and H-Hope Intervention Effects on Patterns of Weight Gain during Hospital Stay for Premature Infants Rosemary White-Traut, PhD, RN, FAAN Kristin.
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
Texas Pediatric Society Electronic Poster Contest
Anemia of Prematurity.
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
Feeding in Very Low Birth Weight neonates on Vapotherm versus CPAP
Gender is a Major Contributor for Increased Tidal Volume Use in Intensive Care Unit A G Sankri-Tarbichi, MD1, S Ansari, MD1, M Zamlut, MD1, and A O Soubani,
Ruth Namazzi, Amos Odiit, Heather Hume, Chandy John, Robert Opoka .
Is Patent Ductus Arteriosus Ligation Responsible for Adverse Outcome in Very Low Birth Weight (VLBW) Infants?  MJ. Qureshi, MD1*, M. Bamehrez, MD1, F.
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Caffeine Use and Brief Resolved Unexplained Events (BRUE)
Case Study: Hypoglycemia/Sepsis Baby Boy Bobby Part I
Alla Kushnir, MD, Judy Saslow MD, Linda Slater-Myer, MD
Transfusion-Related Necrotizing Enterocolitis- A Retrospective Review Diane Farley, RN, BSN, Ellen Mallard RNC, BSN & Christy Wood, RN, BSN RESULTS Mean.
Indication of Blood Transfusion in Newborns Dr Bijan Keikhaei Full Professor of Pediatric Hematology and Oncology Research Center for Thalassemia and.
Correlation of developmental outcome with severity of bronchopulmonary dysplasia in extremely low gestational age neonates Karen Belen, Chengqiu Lu, Narges.
Outcomes in Neonates with Hypoxemic Refractory Respiratory Failure on High-Frequency Oscillatory Ventilator versus High-Frequency Jet Ventilator Alla Kushnir.
Bubble CPAP Best way to treat Respiratory Distress in Neonates
Is benefit of breast feeding in diabetic pregnancies
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
CORRELATION BETWEEN OXYGEN USE AND SYSTEMIC HYPERTENSION
Pediatric consequences of Assisted Reproductive Technologies
HEART FAILURE TEAM MEMBERSHIP
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
National Neonatal Audit Programme 2016
First Hour Care audit data
EXTENT OF CHANGES IN PRE AND POSTDONATION DONOR VARIABLES IN SINGLE AND DOUBLE DOSE PLATELETPHERESIS AND ITS IMPLICATIONS ON DONOR SAFETY Dr. R. Sreedevi.
Nutrition in Premature Infants 3/17/10
Presentation transcript:

Audit of RBC Transfusion in Premature Infants 2001 Dr Ho Hing Tung (Paediatrics) Dr Sherman Lee (Clinical Audit) Dr Raymond Chu (Haematology) Pamela Youde Nethersole Eastern Hospital

Objectives To assess the compliance of RBC transfusion with new guidelines 2001 To assess the effectiveness of new guidelines in reducing the number of RBC transfusions in premature infants

Transfusion Guidelines Beforehand, RBC transfusion according to “Handbook of Blood Transfusion for doctors & nurses PYNEH nd Ed.” New RBC transfusion guideline was implemented from Jan 2001

Old Guidelines 1998New Guidelines 2001 Hct < 40% or Hb < 13 g/dl Oxygen or ventilator dependent Hct  40% Severe Respiratory Illness Ventilator/CPAP, MAP >8 cmH 2 O FiO 2 > 50% Severe congenital heart disease with cyanosis/heart failure Hct < 35% or Hb < 10 g/dl Symptomatic Hct  35% Moderate Respiratory Illness Ventilator/CPAP, MAP 6-8 cmH 2 O FiO % Hct < 27% or Hb < 8 g/dl Asymptomatic Hct  30% Respiratory disease requiring FiO % / nasal cannula O2 1/8-1/4 L/min CPAP/IPPV, MAP <6 cmH 2 O Sustained tachycardia (>180/min) or tachypnoea (>80/min) for 24 hours Apnoea/bradycardia  10/24 hours or  2 requiring bag mask ventilation Cessation of weight gain x 4 days Undergoing major surgery Hct  20% Asymptomatic Blood loss of > 10% of blood volumeAcute blood loss with shock

Method Inclusion criteria: Inborn baby with birth weight  1500 g Date of birth from 1 Sep 1998 to 31 Aug 2001 Date of discharge from 1 Sep 1998 to 30 Oct 2001 Exclusion criteria: Babies not born in PYNEH All perinatal & neonatal deaths before discharge Infants required transfer out of hospital

Method Data collection – Retrospective All neonatal RBC transfusion episodes were retrieved from blood bank Selection of cases according to inclusion & exclusion criteria Trace all old records Subgroup BW < 1000 g BW 1001 – 1500 g Data collection as listed

Data Collection Demographic Name ID Sex Gestation Birth weight DOB DODay 14 DODischarge Length of stay Age attain 2.2 kg Clinical First Hct % at birth Ventilation Days O 2 Days BPD (36 wks PCA) IVH (  G 3) ROP (  G 3) Total no./vol. Transfusion at  2 weeks & > 2 weeks to discharge No. of donor exposure

Data Collection Compliance Indication for transfusion Compliance Old guideline New guideline

Data Analysis Using SPSS 9.0 Chi-square tests for discrete variables Student’s t tests for group means Linear regression for prediction estimation of transfusion Differences considered significant at a p value of < 0.05

Results No. of premature infants included TotalTransfused% Before Sep 1998 – Dec After Jan 2001 – Aug

Baseline Characteristics BW (g)  – – 1500Total Number Gestation (wk)24 – 2927 – 3028 – 3024 – 30 First Hct % [mean(range)] 49 (40.7 – 60) 52.8 (45 – 59) 53.8 (40.7 – 60.7) 51.8 (40.7 – 60.7) Length of Hospital Stay (d) [mean(range)] 127 (74 – 273) 87 (64 –159) 72 (46 –180) 100 (46 – 273) Age attaining weight 2.2 kg (d) [mean(range)] 77 (36 – 99) 63 (47 – 80) 44 (35 – 61) 64 (35 – 99)

Baseline Characteristics BeforeAfterp Number288- Mean birth weight (g) Mean gestation age (wks) Mean Hct at birth (%) Ventilation days (d) O 2 days (d) IVH (  G 3) (%) BPD (%) ROP (  G 3) (%) Phlebotomy blood loss (ml) Length of hospital stay (d) Age attaining weight 2200 g (d)

Comparison of Transfusion Pattern Before & After New Guideline 2001 Mean no. of transfusion episodes/patient Mean vol. of transfusion (ml/kg)/patient Mean Donor no. /patient TotalNo. Trans- fused % Trans- fused Day 14DischargeDay 14Discharge Before After Reduct ion p

Compliance with New Transfusion Guidelines Before (1998 – 2000)After (2001) No. of Transfusion Episodes 8516 % Compliance with Guideline % Compliance with Guideline N/A Ordering of Transfusion % Pre MRCP % Post MRCP % FHKAM3.575 % 2 nd Round

Non-compliance Old guideline -4 episodes Pre-MRCP1 Post-MRCP1 FHKAM2 2 nd Round3 New guideline -1 episode FHKAM1 2 nd Round1

Transfusion & Phlebotomy Loss BW (g)  – – 1500 NICHD 2001* ( ) Total N No. of Transfusion/patient Mean (range) 4 (2 – 7)3 (1-7)2 (1-7) 1.1  (1-7) Transfused % with % with % with % with  Volume (ml/kg/patient) Mean (range) 80 (39 –177) 41 (15 – 95) 23 (14–53) 15  9 51 (14 –177) No. of Donor/patient3 (1- 4)2 (1 –3)2 (1 –4)- Phlebotomy loss  Day 14 (ml/kg/patient)  Phlebotomy loss > Day 14 (ml/kg/patient)

Transfusion Indications BW (g)  – – 1500 NICHD 2001 ( ) Number of Transfusion Episodes  Moderate ventilatory support % Ventilatory respiratory support % No ventilatory supp O 2 or CPAP % Increased O 2 support % Apnoea / Bradycardia % Asymptomatic % Old guideline – Hct < 0.40 % Old guideline – Hct < 0.35 % Old guideline – Hct < 0.27 % Non – compliance %

Blood Investigations Performed Before ( )After (2001) BW (g)  – 1500  – 1500 N Age (day)  14 > 14  14 > 14  14 > 14  14 > 14 CBP (n) Hct (n) RFT (n) LFT (n) ABG (n) Blood Culture (n) Phlebotomy loss (ml/kg)

Risk Factors for Total Volume of Transfusion R 2 = Risk FactorSignificance (p) Total Phlebotomy blood loss< Hct% at birth0.023 Ventilation Days0.025 Birth weight0.370 IVH0.712 BPD0.62 O 2 Days0.944

Discussion Compliance Generally is good Before Old Guideline95.3% New Guideline50.6% After Old GuidelineNA New Guideline93.8%

Discussion Reduction of RBC Transfusion Before 62.2% After 32% Reduction of transfusion may due to More conservative new guideline Decreased phlebotomy blood loss Infants were less ill RBC transfusion rate still higher if comparing with National Institute of Child Health and Human Development (NICHD) 2001

Discussion Reduction of Phlebotomy blood loss (ml/kg) Before  Day 14Day 15 - Discharge  After  Comparable to NICHD 2001

Discussion Implementation of new guidelines can largely reduce the number of blood transfusions in premature infants Reduction of phlebotomy loss contribute significantly to reduction in transfusion requirements Morbidities (BPD, ROP), length of stay & age to attain weight 2.2 kg (growth) were not significantly different with the implementation of new guideline Although our phlebotomy blood loss is comparable to NICHD, our transfusion rate is still higher The total volume of transfusion was largely accounted by phlebotomy blood loss & ventilation days

Discussion Speculation – with modification of guideline, limiting blood loss & use of micro-methods (POCT), non-invasive laboratory monitoring, further more conservative transfusion approach may be adopted ? Use of Erythropoietin for preterm infants in PYNEH

Comparison of Transfusion Guidelines Hct %PYNEH 1998 PYNEH 2001 NICHD 2001  Moderate ventilatory support  40  35 Ventilatory respiratory support  40  35  30 No ventilatory supp O 2 or CPAP  35  30  25 Increased O 2 support  35  30  25 Apnoea / Bradycardia  35  30  25 Asymptomatic  27  20

Thank you

Old guidelines 1998 Hct < 40% or Hb < 13 g/dl if oxygen or ventilator dependent Hct < 35% or Hb < 10 g/dl if symptomatic Hct < 27% or Hb < 8 g/dl if asymtomatic Blood loss of > 10% of blood volume New guidelines 2001 Hct  40%, severe respiratory illness Ventilator/CPAP, MAP >8 cmH 2 O FiO 2 > 50% Severe congenital heart disease with cyanosis/heart failure Hct  35% Ventilator/CPAP, MAP 6-8 cmH 2 O FiO % Hct  30% Respiratory disease requiring FiO % / nasal cannula O2 1/8-1/4 L/min CPAP/  IPPV, MAP <6 cmH 2 O Sustained tachycardia (>180/min) or tachypnoea (>80/min) for 24 hours Apnoea/bradycardia  10/24 hours or  2 requiring bag mask ventilation Cessation of wt gain x 4 days Undergoing major surgery Hct  20% asymptomic Acute blood loss with shock

Risk Factors for Volume of Transfusion  14 days

Risk Factors for Total Volume of Transfusion R 2 = Risk FactorBetaSignificance Total Phlebotomy blood loss0.633< Hct% at birth Ventilation Days Birth weight IVH BPD O 2 Days

Discussion Implementation of new guidelines can largely reduce the number of blood transfusions in premature infants Reduction of phlebotomy loss contribute significantly to reduction in transfusion requirements Morbidities (CLD, ROP), length of stay & age to attain weight 2200 g (growth) were not significantly different with the implementation of new guideline Although our phlebotomy blood loss is comparable to NICHD, our transfusion rate is still higher The total volume of transfusion was largely accounted by phlebotomy blood loss & ventilation days The inverse relationship between Hct% at birth and total volume of transfusion need further analysis